These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16180892)

  • 1. Literature-based generation of hypotheses on chemical composition using database co-occurrence of chemical compounds.
    Milman BL
    J Chem Inf Model; 2005; 45(5):1153-8. PubMed ID: 16180892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
    Valerio LG; Cross KP
    Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances.
    Bercu JP; Morton SM; Deahl JT; Gombar VK; Callis CM; van Lier RB
    Regul Toxicol Pharmacol; 2010; 57(2-3):300-6. PubMed ID: 20363275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and performance evaluation of a database of chemical formulas for the screening of pharmaco/toxicologically relevant compounds in biological samples using electrospray ionization-time-of-flight mass spectrometry.
    Polettini A; Gottardo R; Pascali JP; Tagliaro F
    Anal Chem; 2008 Apr; 80(8):3050-7. PubMed ID: 18336013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of chemical libraries for their druggability.
    Sirois S; Hatzakis G; Wei D; Du Q; Chou KC
    Comput Biol Chem; 2005 Feb; 29(1):55-67. PubMed ID: 15680586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
    Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the performances of quantitative structure-retention relationship models with different sets of molecular descriptors and databases for high-performance liquid chromatography predictions.
    Wang C; Skibic MJ; Higgs RE; Watson IA; Bui H; Wang J; Cintron JM
    J Chromatogr A; 2009 Jun; 1216(25):5030-8. PubMed ID: 19439313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs.
    Lewell XQ; Jones AC; Bruce CL; Harper G; Jones MM; McLay IM; Bradshaw J
    J Med Chem; 2003 Jul; 46(15):3257-74. PubMed ID: 12852756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the investigation and control of process-related impurities in drug substances.
    Argentine MD; Owens PK; Olsen BA
    Adv Drug Deliv Rev; 2007 Jan; 59(1):12-28. PubMed ID: 17189658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques.
    Hommerson P; Khan AM; Bristow T; Harrison MW; de Jong GJ; Somsen GW
    Rapid Commun Mass Spectrom; 2009 Sep; 23(18):2878-84. PubMed ID: 19670338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of a generally applicable method to estimate retrieval of active molecules for similarity searching using fingerprints.
    Vogt M; Bajorath J
    ChemMedChem; 2007 Sep; 2(9):1311-20. PubMed ID: 17562536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database.
    Paulekuhn GS; Dressman JB; Saal C
    J Med Chem; 2007 Dec; 50(26):6665-72. PubMed ID: 18052022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RelACCS-FP: a structural minimalist approach to fingerprint design.
    Hu Y; Lounkine E; Batista J; Bajorath J
    Chem Biol Drug Des; 2008 Nov; 72(5):341-9. PubMed ID: 19012570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separating drugs from nondrugs: a statistical approach using atom pair distributions.
    Hutter MC
    J Chem Inf Model; 2007; 47(1):186-94. PubMed ID: 17238264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical database techniques in drug discovery.
    Miller MA
    Nat Rev Drug Discov; 2002 Mar; 1(3):220-7. PubMed ID: 12120506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shannon entropy-based fingerprint similarity search strategy.
    Wang Y; Geppert H; Bajorath J
    J Chem Inf Model; 2009 Jul; 49(7):1687-91. PubMed ID: 19583222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.